Immunohistochemistry versus microsatellite instability testing in phenotyping coloreetal tumors

Journal of Clinical Oncology

Volumn 20, Issue 4, 2002, Pages 1043-1048

  Lindor, Noralane M ^a   Burgart, Lawrence J ^a   Leontovich, Olga ^a   Goldberg, Richard M ^a   Cunningham, Julie M ^a   Sargent, Daniel J ^a   Walsh Vockley, Catherine ^a   Petersen, Gloria M ^a   Walsh, Michael D ^a   Leggett, Barbara A ^a   Young, Joanne P ^a   Barker, Melissa A ^a   Jass, Jeremy R ^a   Hopper, John ^a   Gallinger, Steve ^a   Bapat, Bharati ^a   Redston, Mark ^a   Thibodeau, Stephen N ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ADULT; AGED; ARTICLE; CANCER GENETICS; COLORECTAL TUMOR; DNA DETERMINATION; GENE; GENE EXPRESSION; HMLH1 GENE; HMSH2 GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PHENOTYPE; PREDICTION; PRIORITY JOURNAL;

AGED; BASE PAIR MISMATCH; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0037083484     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.4.1043     Document Type: Article

References (47)

1. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
2. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability
3. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells
4. The insulin-like growth factor II receptor gene is a target of microsatellite instability in human gastrointestinal tumours
5. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
6. The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": A study of the TGFbetaRII, IGFIIR, and BAX genes
7. Somatic frameshift alteration in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with germline MSH2 mutation
8. Clues to the pathogenesis of familial colorectal cancer
9. Microsatellite instability in colorectal adenocarcinoma cell lines that have full-length adenomatous polyposis coli protein
10. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer
11. APC mutations in colorectal tumors with mismatch repair deficiency
12. Genomic instability in colorectal carcinomas: Comparison of different evaluation methods and their biological significance
13. Clinical implications of microsatellite instability in colorectal cancer
14. Alternative genetic pathways in colorectal carcinogenesis
15. Colorectal cancer with and without microsatellite instability involves different genes
16. Pathogenesis of nonfamilial colorectal carcinomas with high microsatellite instability
17. Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines
18. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
19. K-ras and p53 mutations in hereditary non-polyposis colorectal cancers
20. Molecular genetic alteration and DNA ploidy in hereditary nonpolyposis colorectal cancer
21. Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers
22. Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: Relationship to clinicopathological features and genetic alterations
23. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences
24. Characterization of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways
25. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors
26. Microsatellite instability in cancer of the proximal colon
27. Genomic instability in colorectal cancer: Relationship to clinicopathological viables and family history
28. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer
29. Microsatellite instability in early onset and familial colorectal cancer
30. Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer
31. Immunohistochemical characteristics of colorectal carcinoma with DNA replication error
32. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors
33. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1
34. Predictive value of histopathology for mutator phenotype (microsatellite instability) in colorectal carcinoma
35. Microsatellite instability in sporadic mucinous colorectal carcinomas: Relationship to clinico-pathological variables
36. Morphology of sporadic colorectal cancer with DNA replication errors
37. Microsatellite instability, apoptosis, and the loss of p53 function in drugresistant tumor cells
38. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy
39. The role of DNA mismatch repair in drug resistance
40. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
41. Extensive screening for hereditary non-polyposis colorectal cancer
42. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair
43. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer
44. Immunohistochemistry for hMLH1 and hMSH2: A practical test for DNA mismatch repair-deficient tumors
45. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing
46. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype
47. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer